沙丁胺醇雾化吸入联合沉香饮加减治疗慢性喘息性支气管炎急性发作的疗效观察

目的:对沙丁胺醇雾化吸入联合沉香饮加减用于治疗慢性喘息性支气管炎的临床疗效进行分析与探究。方法:回顾性分析了2009年1月～2011年12月入住我院的20例慢性喘息性支气管炎急性发作的患者的临床资料,并向其加用沙丁胺醇雾化吸入溶液(1ml,每天2次)联合沉香饮加减饮进行治疗,按照相关的疗效评定标准,对本组患者在该种治疗方法下的临床疗效进行分析与观察。结果:①经过上述治疗方法的应用,显效例数12例,有效例数7例,无效例数为1例总有效率为95.0%。在治疗过程中,有2例出现心悸症状,1例出现恶心症状,停药之后不良反应均消失。②治疗前肺功能参数(FEV1与PEFR)要明显低于治疗后(2周),且二者呈现出显著的统计学差异。结论:将沙丁胺醇雾化吸入联合沉香饮加减用于治疗慢性喘息性支气管炎,其临床疗效显著,应该在临床上加以推广并应用。

Efficacy observation on treating acute exacerbation of chronic asthmatic bronchitis with the albuterol inhalation joint the Chenxiang decoction

Objective：To analyze and investigate the clinical effect of treating acute exacerbation chronic asthmatic bronchitis with the albuterol inhalation of joint the Chenxiang decoction.Methods：Retrospective analyzing 20 patients with acute exacerbation of chronic asthmatic bronchitis in our hospital from January 2009 to December 2011,and plus salbutamol solution （1ml,2 times a day） joint the Chenxiang decoction for treatment,in accordance with the evaluation standard,the analysis and observation of clinical efficacy in the treatment of this group of patients.Results：①After treatment,markedly in 12 cases,effective in 7 cases,and ineffective in 1 case,the total effective rate of 95.0%.During treatment,symptoms of palpitations in 2 cases,1 case of patient had symptoms of nausea,and adverse reactions disappear after medicine withdrawal.②Pre-treatment lung function parameters （FEV 1 and PEFR） were significantly lower than after treatment （2 weeks）,and both showed a statistically significant difference.Conclusion：Treating acute exacerbation of chronic asthmatic bronchitis with the albuterol inhalation joint the Chenxiang decoction,its clinical efficacy,should be generalized and applied in clinical.